The Comparison of Conventional and Retzius-Sparing Robot-Assisted Radical Prostatectomy for Clinical, Pathological, and Oncological Outcomes

Abstract

Objective:This study aimed to assess and compare the conventional and Retzius-sparing robot-assisted radical prostatectomy (cRARP and RsRARP) in term of perioperative clinical, pathological, and oncological outcomes.Materials and Methods:This study included 238 consecutive male patients who underwent RARP between May 2008 and November 2020. RARP operations were performed by a single-surgeon. Patients were divided into groups according to the surgical approach and were statistically compared in terms of perioperative clinical, final pathological, and oncological outcomes.Results:The mean age of patients was 64±7 years. cRARP was performed in 134 (56.3%) patients, whereas RsRARP in 104 (43.7%). The frequency of patients with the American Society of Anesthesiologists Class-2 score was higher in the RsRARP group (p0.05, for each).Conclusion:RsRARP allows a safe operation with a shorter surgical time and similar surgical margin positivity, oncological outcomes, and complication rates compared to cRARP.

Keywords

• retzius-sparing
• robot-assisted radical prostatectomy
• radical prostatectomy
• robotics
• prostate cancer